HomeEVLO • OTCMKTS
add
Evelo Biosciences Inc
Previous close
$0.00050
Day range
$0.0015 - $0.0015
Year range
$0.00010 - $0.59
Market cap
31.95K USD
Avg Volume
1.20K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
MarketWatch
1 day ago
Nvidia and the Magnificent Seven make up too much of your high-priced index
fund
0.35%
3.22%
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2023info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.39M | -64.24% |
Net income | -12.36M | 59.55% |
Net profit margin | — | — |
Earnings per share | -0.52 | 90.66% |
EBITDA | -10.22M | 64.22% |
Effective tax rate | 0.14% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 17.26M | -75.00% |
Total assets | 20.63M | -76.11% |
Total liabilities | 47.33M | -38.53% |
Total equity | -26.71M | — |
Shares outstanding | 18.93M | — |
Price to book | -0.00 | — |
Return on assets | -125.34% | — |
Return on capital | -448.00% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2023info | Y/Y change |
|---|---|---|
Net income | -12.36M | 59.55% |
Cash from operations | -10.41M | 53.92% |
Cash from investing | 513.00K | 5,800.00% |
Cash from financing | 19.22M | 2,790.23% |
Net change in cash | 9.28M | 140.41% |
Free cash flow | -5.78M | 50.80% |
About
Founded
2014
Website
Employees
66
